CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies

Clinical trial NCT03765177 · RECRUITING

Trial details

NCT number: NCT03765177
Sponsor: Ottawa Hospital Research Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma Chronic Lymphocytic Leukemia

Start date: 2019-10-16
Primary completion: 2027-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.